Pephexia Therapeutics is a biotechnology company working with the discovery.
Pephexia Therapeutics has raised $1.6M in total funding. The most recent round was Convertible Note. The last funding was announced in September 2021.
Pephexia Therapeutics's investors include BioInnovation Institute.
Pephexia Therapeutics is headquartered in Copenhagen, Denmark.
Pephexia Therapeutics is a biotechnology company working with the discovery.
Pephexia Therapeutics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pephexia Therapeutics — Funding & Investors." VCBacked, September 23, 2021, https://www.vcbacked.co/company/pephexia-therapeutics. Accessed October 10, 2026.
VCBacked. (2021). Pephexia Therapeutics — Funding & Investors. Retrieved October 10, 2026, from https://www.vcbacked.co/company/pephexia-therapeutics
{{cite web |title=Pephexia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pephexia-therapeutics |website=VCBacked |access-date=October 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated